PBMs, the drug price regulators, are at last receiving attention from Washington.

Published Date: 17 May 2023

Patients and doctors have been waiting impatiently for a less expensive version of the most popular drug in the world, Humira, for two decades, while AbbVie, the manufacturer, has fought off potential competitors by erecting a wall of more than 250 patents.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth

2.

Detecting pancreatic cancer through changes in body composition and metabolism

3.

In heavily pretreated DLBCL, Triplet Scores a Survival Victory.

4.

The pandemic had little impact on mental health symptoms.

5.

Men over 75 years old may be significantly more likely to commit suicide if they have cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot